Dr. Joan A. O’Keefe’s lab at Rush University are researching the effect of treadmill training with or without a combined thinking task in people with FXTAS.
Who can participate?
The study is looking for FXTAS patients of any age. You may be able to participate in this study if you are able to stand unassisted and walk for at least 2 minutes.
You will NOT be able to participate in the trial if you have:
- A history of traumatic brain injury, stroke, or multiple sclerosis with changes on CT/MRI.
- Significant cardiopulmonary or cardiovascular disease, dementia, or unstable psychiatric disorders including major depression or schizophrenia.
What will happen in the study?
You will be asked to:
- Walk on a treadmill at your comfortable speed for 20 to 45 minutes or walk on a treadmill while doing a mental exercise for the same duration, 3 times per week for 6 weeks. You will be supported by a safety harness while on the treadmill and carefully monitored throughout.
- Wear sensors around your wrists, ankles, chest, and waist during the balance and walking tests; these are worn outside of your regular clothing.
- Have a short neurological examination and neuropsychological tests.
- Answer questionnaires about your balance confidence and any symptoms of anxiety, sleep, and depression.
- Have blood drawn for measuring the levels of a growth factor in your blood.
- Have an MRI.
- Go through the assessment tests (#2 through #6 above) before the trial and then immediately after, 1-month, and 6-months following the trial.
The time it takes to complete the above tests is 1.5 to 2 hours.
Will you/your child be paid to complete this survey?
Participants will NOT be monetarily compensated for participation in this study.
The testing will be performed in two locations in Chicago:
Rush University Armour Academic Center
600 South Paulina
Rush University Hospital
Kellogg Building Room 235K
1625 West Harrison
For more information
Our Most Recent Opportunities
RTI International and the University of North Carolina at Chapel Hill are conducting an early intervention study to learn about the best ways to support early development in infants identified with the full mutation of Fragile X. Babies 0–9 months old with the full mutation, and their caregivers, may be eligible to participate.
Doctors at Rush University are researching cognition, balance, and walking patterns in people who carry a premutation in the Fragile X (FMR1) gene.
The University of South Carolina is conducting a research study focusing on the range of language, social, and cognitive features that may be associated with variations on the FMR1 gene. Women age 35-75 who are carriers of the Fragile X premutation may be eligible to participate.
An Alliant International University clinical psychology doctoral candidate is conducting a research study to learn about the cognitive profile of children with a full mutation of Fragile X. Males and transgender females between the age of 8 and 12 may be eligible to participate.
The MIND Group at the University of Minnesota is conducting a survey for parents of children with Fragile X syndrome to learn about how genetic and neurodevelopmental differences impact behavioral strengths and challenges. Parents of 3–17 year old children living with Fragile X are eligible to participate.